Flagship Harbor Advisors, LLC Immuno Gen, Inc. Transaction History

Flagship Harbor Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$3.7 - $7.66 $1,110 - $2,298	-300 Closed	0 $0
Q3 2020 Oct 13, 2020	SELL	$3.45 - $4.89 $41 - $58	-12 Reduced 3.85%	300 $1,000
Q2 2020 Jul 31, 2020	BUY	$3.32 - $5.34 $39 - $64	12 Added 4.0%	312 $1,000
Q2 2018 Aug 14, 2018	BUY	$9.52 - $12.15 $2,856 - $3,645	300 New	300 $2,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.